Ovarian Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have hereditary breast and ovarian cancer (HBOC), Lynch syndrome, or a condition involving intestinal polyps, and whose samples are being tested using specific genetic testing tools provided by Sophia Genetics and run on Illumina equipment.
- People with rare or inherited disorders whose samples have already been tested using the same Sophia Genetics and Illumina tools.
- People whose genetic test results have already been written up in a formal report.
- People who have previously given their agreement to participate and have been informed of their genetic test results.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose blood, DNA, or tissue samples are not available for laboratory analysis.
- People whose samples do not meet the required quality standards, which cover things like DNA concentration, DNA condition, and the quality and concentration of the prepared sample library.
- People whose samples do not have consent in place for future research use.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Angelo Minucci, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phone: +390630158602
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Comparation between sequencing platforms
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.